Funding for this research was provided by:
Houston Methodist Research Institute
Received: 17 March 2021
Accepted: 20 July 2021
First Online: 9 August 2021
: The authors are solely responsible for all content, and funders played no role in study design, data collection, and analysis, the decision to publish, or preparation of the manuscript. S.L.L. is an employee of Novartis Pharmaceutical Company; the statements presented in the paper do not necessarily represent the position of the company. The remaining authors have no competing interests to declare.